Non-nucleoside reverse transcriptase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/22 (2006.01) A61K 31/551 (2006.01) A61P 31/18 (2006.01)

Patent

CA 2495744

Compounds represented by formula (1), wherein R1 is H, halogen, (C1-4)alkyl, O(C1-4)alkyl, and haloalkyl; R2 is H or methyl; R3 is H or (C1-4)alkyl; R4 is H or (C1-4)alkyl; R5 is (C1-4)alkyl, (C1-4)alkyl(C3-7)cyclo-alkyl or (C3- 7)cycloalkyl; and W is a fused phenyl-5 or 6-membered heterocycle having one or two heteroatoms selected from N or S; or W is phenyl, 1,1'-biphenyl, 2, 3- dihydro-1H-indene, 1, 2, 3, 4-tetrahydronaphthyl, or naphthyl; said W being optionally substituted with (C1-4)alkyl, which in turn can be optionally substituted with a carboxy or (C1-4)alkoxycarbonyl, or a salt or ester thereof. The compounds have inhibitory activity against Wild Type, single and double mutant strains of HIV.

L'invention a trait à des composés représentés par la formule (1), dans laquelle R?1¿ représente H, halogène, alkyle (C¿1-4?), alkyle O(C¿1-4?), et haloalkyle ; R?2¿ représente H ou méthyle ; R?3¿ représente H ou alkyle (C¿1-4?)¿?; R?4¿ représente H ou alkyle (C¿1-4?) ; R?5¿ représente alkyle (C¿1-4?), cycloalkyle (C¿3-7?) alkyle (C¿1-4?), ou cycloalkyle (C¿3-7?) ; et W représente un phényle-5 fusionné ou un hétérocycle à six éléments, possédant un ou deux hétéroatomes sélectionnés parmi N et S ; ou W représente phényle, 1,1'-biphényle, 2, 3-dihydro-1<I>H</I>-indène, 1, 2, 3, 4-tétrahydronaphtyle, or naphtyle ; W étant éventuellement substitué par alkyle (C¿1-4?), lequel peut à son tour être éventuellement substitué par un carboxy ou alkoxycarbonyle (C¿1-4?). L'invention peut également concerner un sel ou un ester desdits composés. Les composés selon l'invention présentent une activité inhibitrice dirigée contre des souches mutantes simples et doubles de type sauvage du virus VIH.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Non-nucleoside reverse transcriptase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Non-nucleoside reverse transcriptase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-nucleoside reverse transcriptase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1506501

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.